Volver a noticias
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
Premios Fundación Banco Sabadell 2026
El Profesor de Investigación ICREA Marc Güell recibe el XXI premio Fundación Banco de Sabadell a la Investigación Biomédica. La…
El investigador ICREA David R. M. Irving es galardonado con la prestigiossa Dent Medal 2026.
La Royal Musical Association ha concedido a David R. M. Irving, Profesor de Investigación ICREA del Instituto Milà i Fontanals…
